Trade Summary

1 week ago, Henderson Jane, serving as CFO at Apogee Therapeutics, Inc. (APGE), sold 1,500 shares at $80.00 per share, for a total transaction value of $120,000.00. Following this transaction, Henderson Jane now holds 193,371 shares of APGE.

This sale represents a 1.00% decrease in Henderson Jane's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 4 days after the trade was made.

Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.